Results 211 to 220 of about 1,554,916 (325)

Vaccines against COVID-19

Anaesthesia Critical Care & Pain Medicine, 2020
openaire   +2 more sources

Conspiracy Beliefs, Institutional Mistrust, and Health‐Related Behaviours During the COVID‐19 Pandemic in Burkina Faso: A Mediation Analysis

The International Journal of Health Planning and Management, EarlyView.
ABSTRACT Background No study has yet examined the conjoint role of institutional trust and COVID‐19 conspiracy beliefs on compliance with COVID‐19 preventive behaviours among populations of African countries. This study aims to deepen the understanding of the relationship between institutional mistrust, conspiracy beliefs, and health‐related behaviours
Gabin F. Morillon, Marlène Guillon, Jacky Mathonnat   +2 more
wiley   +1 more source

An overview of HLA variants in COVID-19 vaccine-induced autoimmunity. [PDF]

Int J Mol Epidemiol Genet
Bouayad A.
europepmc   +1 more source

Local Responses to Limits on U.S. Public Health Authority During the COVID‐19 Emergency

The International Journal of Health Planning and Management, EarlyView.
ABSTRACT Public health has become politicized in the U.S. Though research shows that limiting public health authority during emergency response puts community wellbeing and health outcomes at risk, during the COVID‐19 emergency (2020–2021), some U.S. state policymakers limited the disease‐preventing actions local public health agencies could take. This
Genevive R. Meredith, Xue Zhang, Zachary M. Batterman, Hannah M. Morris, Zhiwei Chen, Mah Liqa, Mildred E. Warner   +6 more
wiley   +1 more source

Trusted Sources of COVID-19 Vaccine Information by County Characteristics in North Carolina. [PDF]

Vaccines (Basel)
Staley BT, DeWitt ME, Wenner JJ, Sanders JW, Wierzba TF, Poehling K.   +5 more
europepmc   +1 more source

Indicators to identify cancer screening providers with suboptimal case detection: A scoping review

International Journal of Cancer, EarlyView.
What's New? Quality control of cancer screening programs is essential to maintaining high public health standards. Here, the authors reviewed monitoring of case detection in cervical and colorectal cancer screening programs in Europe, and evaluated its effectiveness. They analysed 20 different measures used for this purpose and showed that many of them
Jiayao Lei, Milena Falcaro, Adam R. Brentnall, James F. O'Mahony, Sisse Helle Njor, Matejka Rebolj   +5 more
wiley   +1 more source

Predicting optimal impact interventions in the post‐HPV vaccination world

International Journal of Cancer, EarlyView.
Abstract Prophylactic vaccination is a powerful tool that changes exposure to infections and associated morbidity of preventable diseases. We discuss the impact of pneumococci and human papillomavirus (HPV) vaccination on the population biology of the two micro‐organisms and related public health effects.
Matti Lehtinen, Marc Lipsitch, Ville N. Pimenoff, Karin Sundström, Johannes Berkhof, Iacopo Baussano, Simopekka Vänskä, Joakim Dillner   +7 more
wiley   +1 more source

Factors contributing to COVID-19 vaccine hesitancy in Veterans later in the pandemic. [PDF]

BMC Public Health
Pyne JM, Seal KH, Manuel JK, Kaplan AN, Purcell N, Bertenthal D, Esserman D, Mesidor M, DeRonne BM, Oliver KA, Griffin BJ, Simpson H, Woodruff N, Borsari B, Tobey-Moore L, Usman H.   +15 more
europepmc   +1 more source

Two causes of COVID‐19‐related myocardial injury‐associated cardiogenic shock: Myocarditis and microvascular thrombosis

ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai, Hirohiko Aikawa, Yoshiaki Morita, Keiko Ohta‐Ogo, Teruo Noguchi   +4 more
wiley   +1 more source

Nonavalent HPV vaccine to prevent recurrent anal or vulvar high‐grade squamous intraepithelial lesions (VIVA trial): A randomized, double‐blind, placebo‐controlled trial

International Journal of Cancer, EarlyView.
What's New? Anal and vulvar high‐grade squamous intraepithelial lesions (HSILs) frequently recur following treatment. Additional genital and anal procedures, however, can be distressing for patients and are potentially disfiguring. This trial assessed whether the 9‐valent human papillomavirus (9vHPV) vaccine reduces HSIL recurrence risk or HPV ...
Helen C. Stankiewicz Karita, Amalia S. Magaret, David R. Doody, Jeffrey T. Schouten, Constance Mao, Warner K. Huh, Verena S. Grieco, Matthew A. Seymour, Dana Varon, Kelly H. Shrader, Long Fu Xi, Denise A. Galloway, Anna Wald, Margaret M. Madeleine   +13 more
wiley   +1 more source